Sequoia Financial Advisors, LLC Halozyme Therapeutics, Inc. Put Options Transaction History
Sequoia Financial Advisors, LLC
- $14.6 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HALO
# of Institutions
631Shares Held
128MCall Options Held
408KPut Options Held
384K-
Black Rock Inc. New York, NY17.6MShares$1.17 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$811 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$393 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$229 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$225 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.22B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...